Anzeige
Mehr »
Login
Samstag, 15.02.2025 Börsentäglich über 12.000 News von 686 internationalen Medien
1,5 Mio. Unzen indiziert, 5,2 Mio. Unzen geschätzt - und es wächst weiter: Die Goldaktie mit neuem Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
119 Leser
Artikel bewerten:
(0)

Avant Technologies JV Partner to Speak at AI Revolution in Healthcare Summit in Dubai

Finanznachrichten News

LAS VEGAS, NEVADA / ACCESS Newswire / February 13, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Vinicio Vargas, the co-founder and Chief Executive Officer of Ainnova and member of the board of directors for Ai-nova Acquisition Corp. (AAC), a joint venture formed by both companies, will be a highlighted speaker at the 2025 AI Revolution in Healthcare Summit in Dubai, UAE, on February 15-16.

Vargas, who is spearheading the success of AAC in the AI healthcare industry, will speak to an audience of experts and investors in AI on the clinical adoption of AI and how it is transforming healthcare, improving diagnostics, and expanding access to underserved communities. He will introduce the key drivers of AI adoption, including growing investments in telemedicine and AI-powered imaging, discuss the challenges that remain in data standardization, regulatory compliance, and workforce training, and speak to the importance of collaboration among governments, providers, and tech leaders, which he says is vital for equitable AI integration.

While attending the Summit, Vargas will offer his expertise in the industry as a panelist. He will make up a panel of experts that will explore a range of topics on the ethics in deploying AI in healthcare settings, including:

  • Data Privacy and Security: Ensuring patient confidentiality and safeguarding sensitive information in AI applications.

  • Bias and Fairness: Addressing potential biases in AI algorithms to promote equitable healthcare outcomes.

  • Transparency and Accountability: Maintaining clarity in AI decision-making processes and establishing responsibility for AI-driven outcomes.

  • Regulatory Compliance: Navigating the legal frameworks governing AI deployment in healthcare across different regions.

To learn more about the 2025 AI Revolution in Healthcare Summit in Dubai, visit: https://events.assimilate.one/AI-Revolution-in-Healthcare-Dubai-2025#/?lang=en

About Ainnova Tech, Inc.

Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce VisionAI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.

About Avant Technologies, Inc.

Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI https://www.linkedin.com/company/avant-technologies-ai

https://www.facebook.com/AvantTechAI

https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the

Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.

Contact:

Avant Technologies, Inc.
info@avanttechnologies.com

SOURCE: Avant Technologies



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.